Dr. Wolfe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1010 Main St
Buffalo, NY 14202Phone+1 716-323-0556Fax+1 716-323-6674
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1990 - 1993- University of Pennsylvania Health SystemInternship, Internal Medicine, 1989 - 1990
University of Texas Southwestern Medical SchoolClass of 1989
Certifications & Licensure
CT State Medical License 2022 - 2025
NY State Medical License 2012 - 2025
TX State Medical License 1990 - 2025
PA State Medical License 1991 - 1994- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Buffalo Spree Magazine Castle Connolly, 2013-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy Start of enrollment: 2006 Jun 01
- Efficacy of Prednisone In the Treatment of Ocular Myasthenia Start of enrollment: 2011 Dec 01
- International Guillain-Barré Syndrome Outcome Study Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 632 citationsInternational consensus guidance for management of myasthenia gravis: Executive summaryDonald B. Sanders, Gil I. Wolfe, Michael Benatar, Amelia Evoli, Nils Erik Gilhus
Neurology. 2016-07-26 - 107 citationsInternational Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B. Sanders, Gil I. Wolfe, Michael Benatar, Gabriel Cea
Neurology. 2021-01-19 - 272 citationsReliability testing of the quantitative myasthenia gravis score.Richard J. Barohn, Donald D. McIntire, Laura Herbelin, Gil I. Wolfe, Sharon P. Nations
Annals of the New York Academy of Sciences. 1998-05-01
Press Mentions
COVID-19 May Complicate Neuromuscular Conditions Such as MG, Review FindsAugust 7th, 2020
Pharmacy Times Continuing Education™ to Present Specialty Pharmacy CE Symposia in Washington, D.CAugust 28th, 2019
“Chemical Plasmapheresis” Drug for Myasthenia Gravis Is Safe, Lowers Antibodies, and Produces Hints of Efficacy in Phase 2 TrialJuly 11th, 2019- Join now to see all
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
